Literature DB >> 7717321

Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.

Y Raab1, C Sundberg, R Hällgren, L Knutson, B Gerdin.   

Abstract

OBJECTIVE: To study the synthesis and release of prostaglandin E2 (PGE2) in diseased and healthy areas of the colon in ulcerative colitis/proctitis (UC) patients.
METHODS: Perfusate fluid from rectal and sigmoid segments in patients with UC was analyzed for PGE2, eosinophil cationic protein, myeloperoxidase, and tumor necrosis factor-alpha concentrations. To further elucidate the cell-specific origin of mucosal PGE2 synthesis, double immunofluorescence staining as well as imaging analysis using antibodies reactive with prostaglandin H-synthase and cell-specific antigens were used on surgical colonic specimens from patients with active UC and from controls.
RESULTS: The concentrations of PGE2 were, on average, 10-fold higher in perfusates from diseased areas in patients with UC than in perfusates from healthy areas in patients and controls. The PGE2 values correlated well with the released concentrations of eosinophil cationic protein, myeloperoxidase, and tumor necrosis factor-alpha. In the tissue specimens, there was a prominent colocalization in the expression of prostaglandin H-synthase on the one hand and CD 68 (a macrophage marker) and EG1/EG2 (eosinophil cationic protein markers) on the other hand, in both UC patients and controls. This did not apply to prostaglandin H-synthase and antibodies against B and T lymphocytes, neutrophils, or epithelial cells.
CONCLUSION: The increased PGE2 production found in the inflamed mucosa in active UC may be caused by a fraction of activated eosinophils and macrophages.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7717321

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

1.  Innate immune responses in children and adults with Shigellosis.

Authors:  R Raqib; S M Mia; F Qadri; T I Alam; N H Alam; A K Chowdhury; M M Mathan; J Andersson
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

2.  The role of PGE2 in intestinal inflammation and tumorigenesis.

Authors:  David C Montrose; Masako Nakanishi; Robert C Murphy; Simona Zarini; Jeremy P McAleer; Anthony T Vella; Daniel W Rosenberg
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-10-22       Impact factor: 3.072

3.  The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia.

Authors:  Yasmin Hernandez; John Sotolongo; Keith Breglio; Daisy Conduah; Anli Chen; Ruliang Xu; David Hsu; Ryan Ungaro; Lory A Hayes; Cristhine Pastorini; Maria T Abreu; Masayuki Fukata
Journal:  BMC Gastroenterol       Date:  2010-07-16       Impact factor: 3.067

4.  Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats.

Authors:  Wei-Guo Dong; Shao-Ping Liu; Bao-Ping Yu; Dong-Fang Wu; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

5.  Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis.

Authors:  Wei-Guo Dong; Qiao Mei; Jie-Ping Yu; Jian-Ming Xu; Li Xiang; Yu Xu
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

6.  Combination therapy using fexofenadine, disodium cromoglycate, and a hypoallergenic amino acid-based formula induced remission in a patient with steroid-dependent, chronically active ulcerative colitis.

Authors:  M Raithel; S Winterkamp; M Weidenhiller; S Müller; E G Hahn
Journal:  Int J Colorectal Dis       Date:  2006-03-31       Impact factor: 2.796

7.  Cytokines in inflammatory bowel disease.

Authors:  P L Beck; J L Wallace
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

Review 8.  Prostaglandins and Their Receptors in Eosinophil Function and As Therapeutic Targets.

Authors:  Miriam Peinhaupt; Eva M Sturm; Akos Heinemann
Journal:  Front Med (Lausanne)       Date:  2017-07-19

9.  Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis.

Authors:  Natsuki Ishida; Takahiro Miyazu; Ryosuke Takano; Satoshi Tamura; Shinya Tani; Takuma Kagami; Mihoko Yamade; Yasushi Hamaya; Moriya Iwaizumi; Satoshi Osawa; Takahisa Furuta; Hiroaki Miyajima; Ken Sugimoto
Journal:  BMC Gastroenterol       Date:  2020-04-19       Impact factor: 3.067

10.  Prostaglandin E-major urinary metabolite diagnoses mucosal healing in patients with ulcerative colitis in remission phase.

Authors:  Toshiyuki Sakurai; Yoshihiro Akita; Haruna Miyashita; Ryosuke Miyazaki; Yuki Maruyama; Tomoko Saito; Mariko Shimada; Takuji Yamasaki; Seiji Arhihiro; Tomohiro Kato; Tomokazu Matsuura; Masahiro Ikegami; Isao Okayasu; Masayuki Saruta
Journal:  J Gastroenterol Hepatol       Date:  2022-02-14       Impact factor: 4.369

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.